SCHEMBL28045596

SCHEMBL28045596

CN(C)c1ccc(C=C2CCn3c2nc2ccccc2c3=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.65
▸ NPC1 O15118 3/20 0.65
▸ ALOX5 P09917 2/20 0.61
▸ MAPT P10636 2/20 0.55
▸ CCR3 P51677 1/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ KMT2A Q03164 6/20 0.54
▸ MEN1 O00255 5/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.50
▸ NME2 P22392 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28045595 0.86 MEN1 (0.66) KMT2AMEN1
SCHEMBL10853060 0.81 KMT2A (0.55) RAB9AMAPTKMT2AMEN1ALDH1A1
SCHEMBL10849598 0.80 KMT2A (0.56) RAB9ANPC1ALOX5MAPTKMT2A
SCHEMBL29519449 0.80 NPC1 (0.62) RAB9ANPC1ALOX5MAPTCCR3
SCHEMBL29519532 0.79 RAB9A (0.68) RAB9ANPC1ALOX5MAPTCCR3
SCHEMBL21992755 0.79 RAB9A (1.00) RAB9ANPC1ALOX5MAPTCCR3
SCHEMBL14882372 0.79 RAB9A (1.00) RAB9ANPC1ALOX5MAPTCCR3
SCHEMBL11086290 0.79 NPC1 (0.61) RAB9ANPC1ALOX5MAPTCCR3
SCHEMBL11086293 0.79 NPC1 (0.61) RAB9ANPC1ALOX5MAPTCCR3
SCHEMBL10851747 0.78 KMT2A (0.54) RAB9ANPC1ALOX5MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105272986-A A compound for inhibiting acetylcholinesterase activity, and preparation method and uses thereof XIAMEN MEDICAL COLLEGE 2016-01-27 — — CN disclosed
Send feedback